Trends in Opioid Use during Hospitalization following Revision Total Hip Arthroplasty from 2016 to 2021

Abstract

Though opioids can be very effective for postoperative pain management after revision total hip arthroplasty (rTHA), many physicians have made an effort to decrease usage of these medications by focusing on alternative pain management strategies to reduce opioid dependence and unwanted side effects. This study sought to investigate trends in opioid consumption during hospitalization following rTHA from 2016 to 2021. We retrospectively reviewed all patients who received rTHA from January 2016 to April 2021. Baseline demographic variables including age, gender, race, body mass index, and American Society of Anesthesiologists classification were recorded. Additional information including patient-reported outcome measures (PROMs), postoperative outcomes, dosage, and type of opioid medication prescribed postoperatively were also collected. Opioid dosage and type were converted to milligram morphine equivalents (MMEs) per day of hospitalization and compared across the 6 years studied. Linear regression as well as t-tests were utilized to determine significant trends in MME consumption over time. In total, 1,096 patients met inclusion and exclusion criteria. The greatest daily average opioid consumption per patient was in 2017 (61.6 ± 155.4 MME per day) and the lowest was in 2021 (31.8 ± 105.8 MME per day). Linear regression analysis detected a downward trend of 4.97 MME per day each year, though these results were not statistically significant (R ²: 0.444, p = 0.089). t-Test analysis, however, did reveal a significant decrease in opioid consumption in the postprotocol cohort (38.41 ± 90.5 vs. 52.18 ± 120.2; p = 0.034). There was a significant increase in preoperative Hip Disability and Osteoarthritis Outcome Score, Joint Replacement scores (p = 0.007) over time as well as a significant decrease in preoperative visual analog scale pain scores (p = 0.012). The results of this study show that opioid consumption in 2021 was lower than in 2016 and 2017. This result emphasizes the effectiveness of protocols limiting opioid usage during hospitalization following rTHA. Moreover, the relatively consistent patient-reported outcome scores over time demonstrate that this decrease in opioid consumption per year does not impact patient-reported outcomes and satisfaction.

Keywords

revision - arthroplasty - opioids - pain management

Publication History

Received: 04 October 2022

Accepted: 17 November 2023

Article published online:
19 January 2024

• References

• 1 Knight SR, Aujla R, Biswas SP. Total hip arthroplasty - over 100 years of operative history. Orthop Rev (Pavia) 2011; 3 (02) e16
• 2 Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988; 10: 1-28
• 3 Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91 (01) 128-133
• 4 Springer BD, Fehring TK, Griffin WL, Odum SM, Masonis JL. Why revision total hip arthroplasty fails. Clin Orthop Relat Res 2009; 467 (01) 166-173
• 5 Gaffney CJ, Pelt CE, Gililland JM, Peters CL. Perioperative pain management in hip and knee arthroplasty. Orthop Clin North Am 2017; 48 (04) 407-419
• 6 Højer Karlsen AP, Geisler A, Petersen PL, Mathiesen O, Dahl JB. Postoperative pain treatment after total hip arthroplasty: a systematic review. Pain 2015; 156 (01) 8-30
• 7 Khaw D, Bucknall T, Considine J. et al. Six-year trends in postoperative prescribing and use of multimodal analgesics following total hip and knee arthroplasty: a single-site observational study of pain management. Eur J Pain 2021; 25 (01) 107-121
• 8 Buvanendran A, Kroin JS, Tuman KJ. et al. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA 2003; 290 (18) 2411-2418
• 9 Kukreja P, Avila A, Northern T, Dangle J, Kolli S, Kalagara H. A retrospective case series of Pericapsular Nerve Group (PENG) block for primary versus revision total hip arthroplasty analgesia. Cureus 2020; 12 (05) e8200
• 10 Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol 2009; 28 (12) 1419-1430
• 11 Saleh KJ, Celebrezze M, Kassim R. et al. Functional outcome after revision hip arthroplasty: a metaanalysis. Clin Orthop Relat Res 2003; (416) 254-264
• 12 Tan TL, Rondon AJ, Wilt Z. et al. Understanding opioid use after total hip arthroplasty: a comprehensive analysis of a mandatory prescription drug monitoring program. J Am Acad Orthop Surg 2020; 28 (20) e917-e922
• 13 Ochalek TA, Cumpston KL, Wills BK, Gal TS, Moeller FG. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic. JAMA 2020; 324 (16) 1673-1674
• 14 Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend 2020; 214: 108176
• 15 Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese SD. Current perspectives on the opioid crisis in the US healthcare system: a comprehensive literature review. Medicine (Baltimore) 2019; 98 (20) e15425
• 16 Brat GA, Agniel D, Beam A. et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ 2018; 360: j5790
• 17 Hill MV, Stucke RS, McMahon ML, Beeman JL, Barth Jr RJ. An educational intervention decreases opioid prescribing after general surgical operations. Ann Surg 2018; 267 (03) 468-472
• 18 Karam JA, Schwenk ES, Parvizi J. An update on multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 2021; 103 (17) 1652-1662
• 19 Parvizi J, Miller AG, Gandhi K. Multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 2011; 93 (11) 1075-1084
• 20 Kehlet H, Werner M, Perkins F. Balanced analgesia: what is it and what are its advantages in postoperative pain?. Drugs 1999; 58 (05) 793-797
• 21 Parvizi J, Bloomfield MR. Multimodal pain management in orthopedics: implications for joint arthroplasty surgery. Orthopedics 2013; 36 (2, Suppl): 7-14
• 22 Pepper AM, Mercuri JJ, Behery OA, Vigdorchik JM. Total hip and knee arthroplasty perioperative pain management: what should be in the cocktail. JBJS Rev 2018; 6 (12) e5
• 23 National Center for Injury Prevention and Control. CDC compilation of benzodiazepines, muscle relaxants, stimulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors. Centers for Disease Control and Prevention; ; June 4, 2021
• 24 Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011; 63 (Suppl. 11) S240-S252
• 25 Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology 2009; 111 (03) 657-677
• 26 Quinlan J, Rann S, Bastable R, Levy N. Perioperative opioid use and misuse. Clin Med (Lond) 2019; 19 (06) 441-445
• 27 Dwyer MK, Tumpowsky CM, Hiltz NL, Lee J, Healy WL, Bedair HS. Characterization of post-operative opioid use following total joint arthroplasty. J Arthroplasty 2018; 33 (03) 668-672
• 28 Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med 2011; 12 (05) 747-754
• 29 Reid DBC, Shah KN, Shapiro BH, Ruddell JH, Akelman E, Daniels AH. Mandatory prescription limits and opioid utilization following orthopaedic surgery. J Bone Joint Surg Am 2019; 101 (10) e43
• 30 Reid DBC, Shapiro B, Shah KN. et al. Has a prescription-limiting law in rhode island helped to reduce opioid use after total joint arthroplasty?. Clin Orthop Relat Res 2020; 478 (02) 205-215
• 31 Wakeman SE, Green TC, Rich J. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nat Med 2020; 26 (06) 819-820
• 32 Wainwright JJ, Mikre M, Whitley P. et al. Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak. JAMA 2020; 324 (16) 1674-1677
• 33 Randall DJ, Vanood A, Jee Y, Moore DD. National and state level opioid-restricting legislation in total joint arthroplasty: a systematic review. J Arthroplasty 2022; 37 (01) 176-185
• 34 Wilson JM, Farley KX, Erens GA, Bradbury TL, Guild III GN. Preoperative opioid use is a risk factor for complication following revision total hip arthroplasty. Hip Int 2022; 32 (03) 363-370
• 35 Pivec R, Issa K, Naziri Q, Kapadia BH, Bonutti PM, Mont MA. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. Int Orthop 2014; 38 (06) 1159-1165
• 36 Smith E, Klemt C, Sabeh K, Tirumala V, Kwon YM. Patient-reported outcomes associated with preoperative opioid use in revision total hip arthroplasty: a propensity score-matched cohort study. J Am Acad Orthop Surg 2021; 29 (07) e330-e336